Procter & Gamble (NYSE:PG) Price Target Cut to $189.00 by Analysts at UBS Group

Procter & Gamble (NYSE:PG) had its price target decreased by UBS Group from $196.00 to $189.00 in a report published on Thursday morning,Benzinga reports. UBS Group currently has a buy rating on the stock.

A number of other research analysts also recently weighed in on PG. Morgan Stanley raised their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. DA Davidson restated a “buy” rating and set a $209.00 target price on shares of Procter & Gamble in a report on Friday, December 27th. Wells Fargo & Company cut their price target on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Finally, Evercore ISI raised their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $180.05.

Procter & Gamble Stock Performance

Shares of PG opened at $160.54 on Thursday. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. Procter & Gamble has a 12 month low of $146.28 and a 12 month high of $180.43. The firm has a fifty day simple moving average of $169.37 and a 200 day simple moving average of $169.45. The stock has a market capitalization of $378.08 billion, a price-to-earnings ratio of 27.68, a PEG ratio of 3.41 and a beta of 0.45.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter last year, the company earned $1.83 EPS. Procter & Gamble’s revenue for the quarter was down .6% compared to the same quarter last year. Research analysts forecast that Procter & Gamble will post 6.93 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend is Friday, January 24th. Procter & Gamble’s dividend payout ratio is 69.48%.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the sale, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 75,439 shares of company stock valued at $13,317,460 in the last quarter. Company insiders own 0.18% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently modified their holdings of the business. Itau Unibanco Holding S.A. acquired a new stake in Procter & Gamble in the second quarter valued at about $28,000. RPg Family Wealth Advisory LLC bought a new position in shares of Procter & Gamble in the third quarter worth about $33,000. Quest Partners LLC acquired a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $36,000. Costello Asset Management INC grew its holdings in shares of Procter & Gamble by 2,142.9% during the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company’s stock valued at $54,000 after purchasing an additional 300 shares during the last quarter. Finally, William B. Walkup & Associates Inc. acquired a new position in Procter & Gamble during the 2nd quarter worth approximately $58,000. Institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.